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Background: Modalities (undersizing annuloplasty – UA- vs mitral valve
replacement – MVR-) and outcome of surgical treatment of functional mitral
regurgitation (FMR) are still debated.
Objectives: Early and mid-term outcome of patients operated for symp-
tomatic severe FMR; Comparison of respective results of UA and MVR.
Methods: Inclusion criteria: Severe FMR due to either ischemic or non
ischemic cardiac disease; Heart failure symptoms despite optimal medical
treatment; LVEF<40%.Primary endpoints: In-hospital mortality; Late CV
mortality Secondary endpoints: Evolution of LVEF after surgery; Recur-
rence of MR.
Results: 59 consecutive patients included between 1997 and 2011, mean
age=65±10,i schemic disease in 41 (70%),heart failure symptoms in all,
LVEF= 36±6%,ERO=41±17 mm².Surgical procedures included 12UA and
47 MVR with only 8 (13%)concomitant CABG. MVR and UA groups were
comparable for age, ischemic etiology, LVEF, ERO and sPAP (all p>0.5).In-
hospital mortality: 3.3% overall, 8.3% in UA group and 2.1% in MVR group
(p=0,36).Eight-year survival free from CV death: 58±13% in the total
population, 60±18% in the UA group and 72±10% in the MVR group
(p=0.48). By multivariable analysis, older age (1.22 [1,05-1,42], p=0,008) and
LV end-diastolic diameter (1.25 [1.05-1.49], p=0,01) independently predicted
late mortality with borderline effect of pre-op LVEF (1.1[0.99-1.2], p=0,08)
whereas type of surgery did not (1.7 [0,38-7.55], p=0.48). LVEF did not
change between pre-op and late FU echo in the MVR group (36±6% vs
36±10%, p=0.68) but tended to decrease in the UA group (37±5.8% vs
31±12%, p=0.1). In the UA group, 50% of patients experienced recurrence of
significant MR (mean post-op ERO=19±4 mm²) whereas no patients in the
MVR group presented with post-op MR.
Conclusions: Despite severe clinical and echocardiographic presentation,
surgical treatment of FMR can be performed with an acceptable operative risk
and mid-term survival. MVR is a reasonable approach, which does not expose
patients to MR recurrence, particularly frequent after UA.
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Minimally invasive approach for mitral valve surgery, as safe and as
reliable than sternotomy. Does it should be the standard approach?
Experience in 368 patients
Vincent Doisy, Marc Vigneron, Fabrice Wautot, Jean-Philippe Frieh,
Nicolas Chavanis, Alain Curtil
Clinique du Tonkin, Villleurbanne, France
To assess the reliability of minimally invasive approach, as this approach
is contest in France we review part of our experience in one center.
Methods: From January 2009 to April 2012, 368 patients were operated of
isolated mitral surgery in a single center. In a retrospective study we analyze
follow-up with focus on surgical approach to emphasize on the safety of min-
imally invasive strategy.
During that period video-assisted procedure was perform for 222 patients
and 146 underwent standard sternotomy.
Results: Results on different parameters are analyzed, we report no dif-
ference in mortality, in-hospital stay length, stroke, bleeding, use of cate-
cholamine between the two groups. Cross clamping, ECC times were longer
in minimally invasive group. ICU time was longer in standard sternotomy
group. In terms of results in efficiency upon plasty results, results were
better in the minimally invasive group with 90,4% success of plasty when
planned.
All parameters are detailed in the study.
Reliability of the procedure is modulated by experience of surgeon, two
surgeons are mainly involved in minimally invasive program, they are more
experienced in mitral plasty so that explain good repair vs replacement rate in
this group.
Conclusion: On the basis of this retrospective study we conclude than
minimally invasive approach is as safe as standard approach for mitral surgery
and as reliable on repair rate in mitral regurgitation.
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Background: The aim of this study is to assess the impact of preoperative
AF on outcome in patients undergoing MVR for mitral valve prolapse (MVP).
Methods: Between 1991 and 2009, 348 consecutive patients underwent
MVR for MR due to MVP (follow-up: mean duration 105±50 months).
Echocardiography was performed preoperatively and 9 to 12 months after sur-
gery. Post operative left ventricular dysfunction (LVD) was defined as ejec-
tion fraction (EF) < 50%. Results: There were 81 patients (23.3%) in AF at
baseline. Preoperative EF decreased from 67.2±9.6% to 58.9±10.1% post
operatively (p< 0.0001). Patients in AF were older (70±9 vs. 64±11 years,
p<0.0001), more often in NYHA III – IV class (p=0.028), had a significantly
higher EuroSCORE (4.4±5.7 vs. 2.8±2.4, p<0.0001). At baseline, patients in
AF had a lower preoperative EF (64±11 vs. 68±9%, p=0.001). Early mortality
was 4.9% in patients with preoperative AF vs. 1.9% in sinus rhythm (n=5,
p=0.13). Multivariate analysis did not identify AF as a predictor of early mor-
tality whereas EuroSCORE (p =0.001) and low pre-operative EF (p=0.001)
were independent risk factors for early mortality. On multivariate analysis
adjusted for EuroSCORE, NYHA III – IV class and preoperative LVEF, pre-
operative AF was identified as an independent predictors of overall mortality
(OR 1.9; p=0.03) and of occurrence of heart failure (OR 2.2, p=0.054). After
adjustment for gender, EuroSCORE, NYHA III-IV class and preoperative EF,
preoperative AF and pre-operative EF were the 2 predictors of post-operative
LVD (OR 2.2 p=0.025 and OR 1.04, p=0.03 respectively).
Conclusion: Preoperative AF is an independent predictor of long term
mortality and post-operative LVD after MVR for MPV.
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Purpose: Percutaneous mitral commissurotomy (PMC) has enabled
patients (pts) to be treated at an earlier stage of their disease than by surgery.
However, very long-term results have not been specifically studied in this
context.
Methods: From 1986 to 1995, 237 patients in NYHA class I or II under-
went PMC in our department. Mean age was 46±12 years; 74 patients (31%)
had atrial fibrillation and 22 (9%) had a history of commissurotomy. Most
patients were in NYHA class II (232 pts, 98%). As assessed by echocardio-
graphy, mean valve area was 1.1±0.2 cm² (≤1.5 cm² in all cases); 40 patients
(17%) had pliable valves and mild subvalvular disease, 145 (61%) had severe
subvalvular disease, and 52 (22%) had calcified valves. PMC used a single-
balloon in 5 pts, a double-balloon in 93 and the Inoue balloon in 139.
Results: After PMC, valve area increased to 1.9±0.3 cm² as assessed by
2D echo. Severe mitral regurgitation (grade ≥3/4) occurred in 4 patients
(1.7%). There were no other severe immediate complications. Good imme-
diate results (valve area ≥1.5 cm² without mitral regurgitation >2/4) were
obtained in 223 patients (94%). The 20-year actuarial rate of survival without
surgery or repeat PMC and in NYHA class I or II was 41±4% in the whole
population.
After good immediate results, the 20-year rate of good functional results
was 42±3%. A Cox multivariate model identified 2 predictors of good late
functional results after good immediate results: young age (p=0.05) and a
large valve area after PMC (p=0.002). In the 142 patients aged ≤50 years, the
20-rate of good functional results was 50±6%.
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Conclusion: In patients with severe mitral stenosis and few or no symp-
toms, PMC: 1) Can be safely performed 2) Provides good immediate and
long-term results in a large variety of patients. 3) Should be considered in par-
ticular in patients aged ≤50 years, in whom it prevents functional deterioration
in half of the cases 20 years after PMC.
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Introduction: Percutaneous mitral commissurotomy (PMC) is the alterna-
tive treatment of choice for mitral stenosis (MS). Its immediate and medium
term results are comparable to those of surgical commissurotomy, however in
the long term there is a risk of restenosis. The purpose of this study is to deter-
mine the factors predicting restenosis after PMC.
Methods: 322 patients (66% women), average age: 35 ±13 years (9-75 years)
having a tight MS and treated by PMC with Inoué balloon. The anatomic
aspect of the mitral apparatus before PMC has been studied according to the
criteria of the Wilkins score with a concomitant study of the state of mitral
commissures. The primary success of PMC is defined as follows: mitral area
(MA) post-PMC >1,5 cm2 and gain in MA >25% and mitral regurgitation
(MR) ≤ grade 2. Mitral restenosis is defined as a MA <1,5 cm2 and/or loss
>50% of initial gain in MA.
Results: The rate of primary success of PMC was 86% and mean MA post
PMC was 1,82±0,33 cm² compared to MA pre-PMC of 1±0,18 cm² (p <0.0001).
Opening of two commissures has been observed in 74% of patients. After an
average period of 62±32 months, only 12% of patients had a dyspnea stage III-
IV of NYHA, MA was 1,64±0.3 cm² (p<0.001) and mitral restenosis happened
in 47 patients (20%) after a period of 60,48±27 months (22 – 124 months).
The independent predictors of mitral restenosis after a successful PMC
were: previous surgical commisurotomy, Wilkins score >8, MA after PMC
<1,8 cm² and absence of bicommissural opening post PMC.
Conclusion: A favorable anatomy of mitral apparatus and the optimisation
of immediate result of PMC are the guaranty for the maintain of good result
in the long term.
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Methods: We performed percutaneous mitral balloon commisurotomy
(PMC) in 361 patients to compare the effectiveness of PMC between patients
with mitral restenosis after surgical commissurotomy (group 1) and patients
with unoperated mitral stenosis (group 2). Thirty-nine had undergone closed
or open mitral commissurotomy 8.4 years before.
Results: There were no significant differences in clinical profiles between
the two groups. The mitral valve area was increased from 1.1 0.31 to 1.94
0.58 cm2 in group 1 and 0.94 0.3 to 2 0.7 cm2 in group 2 (p>0.05). The mitral
gradient was decreased from 14.6 5.9 to 6 2.6 mm hg in group 1 and 18 7.0
to 7 5.3 mm hg in group 2 (p>0.05). The increment of mitral regurgitation and
significant left to right shunt after PMC were not significantly different (8.9%
versus 13.7%, 4.2% versus 8.4% respectively). Optimal results were attained
in 81% of the patients in group 1 and in 88.3% of the patients in group 2
(p>0.05).
Conclusion: These results suggest PMC in mitral restenosis after surgical
commissurotomy may be safe in selected patients and may be equally effec-
tive as in unoperated mitral stenosis.
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Relationship between cut-off values of peak aortic valve velocity and
those of other Doppler echocardiographic parameters of severity in
patients with aortic stenosis and normal flow
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Background: Previous studies have reported inconsistencies between
echocardiographic parameters of severity in aortic valve stenosis (AS). Peak
aortic valve velocity (Vmax) strongly predicts outcome in AS patients. The
present study was therefore designed to identify the cut-off values of echocar-
diographic parameters of severity in normal flow (NF) AS corresponding to a
Vmax ≥3 m/s, ≥4 m/s, 5 m/s or 5.50 m/s. This study was therefore designed to
identify the cut-off values of echocardiographic parameters of severity that
correspond to Vmax≥3, 4, 5 and 5.5 m/s.
Methods and results: We retrospectively reviewed the echocardiograms
of 528 consecutive patients with AS, left ventricular (LV) ejection frac-
tion>0.50 and NF (stroke volume index>35 mL/m²). The accuracy of mean
pressure gradient (MPG), aortic valve area (AVA), and indexed AVA for BSA
(IAVA) to predict Vmax≥3, 4, 5 and 5.5 m/s ranged from 0.89 to 0.99, and
the best predictor was MPG for various levels of Vmax. The best values of
MPG, AVA, and IAVA to predict Vmax≥3 m/s were 22 mmHg, 1.15 cm2,
0.60 cm2/m2, respectively. While a cut-off of Vmax≥4 m/s to define severe AS
was consistent with a value of 39 mmHg for MPG, corresponding values for
AVA and IAVA of 0.90 cm² and 0.48 cm²/m² respectively were substantially
different from those recommended in current guidelines. MPG≥60 and
65mmHg, AVA≤0.76 and ≤0.68 cm², and IAVA≤0.41 and ≤0.35 cm2/m2 were
identified as predictors of Vmax≥5 m/s and ≥5.5 m/s (very severe AS), respec-
tively.
Conclusions: Guidelines recommended cut-off values for AVA and IAVA
are not consistent with those of Vmax and MPG. The results of the present
study may serve as safeguards in case of apparent inconsistencies between
echocardiographic parameters of severity in NF AS.
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Background: The exact prevalence, characteristics and impact on both
short- and long-term outcome of low flow, low gradient severe aortic stenosis
(LFLG) despite preserved left ventricular ejection fraction (LVEF), remain
debatable. The aim of our study is to describe the outcome of a large group of
patients with LFLG AS using cardiac catheterization data.
Methods and Results: Between 2000 and 2010, 770 patients with pre-
served LVEF (>50%) and severe AS (valve area <1cm²) without significant
other valvular heart disease having underwent cardiac catheterization, were
retrospectively analyzed. Mean age was 74±8 years, 42% were female, 46%
had associated coronary artery disease. LFLG (indexed LV stroke
volume<35 mL/m² and mean pressure gradient<40 mm Hg) were found in
13% of patients (n=99), normal flow/high gradient (NFHG) in 50% (n=388),
LFHG in 14% and NFLG in 22%.
In comparison with classical patients with NFHG, those with LFLG were
significantly older, and more often female. The cardiac cathererization hemo-
dynamic data including the systemic compliance, vascular systemic resis-
tances and the valvulo-arterial impedance were significantly impaired in
LFLG patients as compared to those with NF/HG. Thirty-days mortality was
higher in patients with LFLG when compared to NFHG (9 vs. 4%, p=0.06)
and 10-year survival was significantly reduced in LFLG (32±8%) when com-
pared to NFHG (66±4%; p=0.0005) (figure). Furthermore, after adjustment for
